On October 23, NCI rose 3.27% intraday in regular trading, trading at HK$39.06, with turnover of HK$184 million.
The move coincided with a broader rebound in Hong Kong-listed insurers, while the company’s announced interim dividend of HK$0.85230789 per share payable on December 10 and its scheduled third-quarter results release on October 30 helped lift market attention.
Recent disclosures show NCI will hold a third-quarter earnings briefing on October 30 after results are released. Market positioning on life insurers has remained cautious in the near term, mainly due to equity-market volatility and a high comparison base potentially weighing on third-quarter earnings growth. At the same time, expectations that the year-ago premium base began to ease from September and that the shift toward participating insurance products may improve business quality have offered some support for valuation repair.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments